Cenkos Securities

Cenkos Securities was a leading independent UK institutional stockbroker and corporate finance advisor, primarily focused on the London Stock Exchange's AIM market. While the firm operated as a financial services provider rather than a drug developer, it was a major force in the life sciences and healthcare sectors, providing brokerage and advisory services to numerous biotechnology companies. Cenkos specialized in capital raising, equity research, and Nominated Adviser (NOMAD) services for growth-oriented firms. In September 2023, the company completed a merger of equals with FinnCap Group to form Cavendish Financial plc. This merger combined their expertise to create a dominant mid-market investment bank in the UK. Throughout its history, Cenkos was instrumental in the public listings and financing rounds of several prominent UK-based healthcare entities.